Eli Lilly lowered Zepbound’s starter dose to $349 per month The lower prices are available for uninsured patients and folks whose insurance doesn't cover the drugs FRIDAY, March 7, 2025 ...

Following consumer complaints, the manufacturers of weight loss drugs Wegovy and Zepbound have announced significant price drops in a move that could allow more Americans to access those medications.

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly Penn State wrestler who made beeline for Trump after winning title speaks out 'We're Going to Be Fighting for ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. "It's about the size of a small city," says David Ricks, Eli Lilly's CEO. That's about 10% of the 1 ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

That's different from drugs such as Novo Nordisk's Ozempic or Lilly's Zepbound, which involve the hormone GLP-1. Shares of AbbVie gained more than 1% intraday Monday and are up nearly 20% since ...

The campaign comes as Eli Lilly steps up its crackdown on unauthorized versions of its weight-loss drugs and as Zepbound emerges from a prolonged stint on the FDA’s drug-shortage list. Zepbound ...

Throughout last year’s entertainment awards season, Lilly took aim at the popular off-label use of GLP-1 drugs like its Mounjaro and Zepbound for cosmetic weight loss. A commercial released ...

Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 billion in four new manufacturing sites in the United States. But the ...